The new WHO global strategic initiative encouraged countries to adopt digital health tools to support universal health coverage.

In patients with plaque psoriasis, family history and palmoplantar involvement were among the predictors of early super response to bimekizumab.

Black and Hispanic patients with MCC are more likely to have tumors on UV-protected sites, which is associated with better outcomes.

Concomitant IBD reduces disease control and treatment response among patients with PsA receiving biologic therapy.

Ixekizumab was more effective for the treatment of mild to moderate psoriasis vs severe psoriasis at most time points through 52 weeks.

Credit: Getty Images Clinical guidelines on the management of atopic eczema have been updated to reflect new and expanded medication approvals. An updated evidence- and consensus-based living ...

This is a comprehensive table of dermatology ICD-10 codes used by researchers and healthcare professionals and personnel – nurses, medical coders, physicians, et al. This table has been curated for ...

Skin wrinkles may occur due to ageing, sun damage, smoking, poor hydration, habitual facial expressions (such as grinning, pouting, frowning, squinting) and sleeping positions. The Conversation — You ...

A 31-year-old man presents to a homeless clinic complaining of a papular rash located on the occipital region of his scalp. The rash initially began several years earlier. A 31-year-old man presents ...

Habitual scratching was reported by 44.5% of adults and 57.5% of children with atopic dermatitis, who often only became aware of these actions when it was pointed out by someone else. Children and ...

An up-to-date review for dermatologists on ocular manifestations of lichen planus (LP), lichen planus pigmentosus (LPP), and lichen planopilaris (LPL), as well as guidelines on when to refer patients ...

The United States Food and Drug Administration reported changes in drug approvals, warnings, and indications for products for dermatologic use in 2024. Throughout 2024, the Food and Drug ...